Clinical and experimental bacteriophage studies: Recommendations for possible approaches for standing against SARS-CoV-2. (March 2022)

• Record Type: Journal Article
• Authors: Shahin, Khashayar; Zhang, Lili; Mehraban, Mohammad Hossein; Collard, Jean-Marc; Hedayatkhah, Abolghasem; Mansoorianfar, Mojtaba; Soleimani-Delfan, Abbas; Wang, Ran
• Is Part Of: Microbial pathogenesis. Volume 164(2022)
• Publication Date: 2022-03
• Subjects: Phage -- Bacteriophage -- Phage therapy -- COVID-19 -- SARS-CoV-2; Pathogenic microorganisms -- Periodicals; Pathology, Molecular -- Periodicals; Communicable Diseases -- microbiology -- Periodicals; Communicable Diseases -- parasitology -- Periodicals; Micro-organismes pathogènes -- Périodiques; Pathologie moléculaire -- Périodiques; Electronic journals; 616.9041
• DOI: 10.1016/j.micpath.2022.105442
• Languages: English
• ISSNs: 0882-4010

Abstract

Abstract: In 2019, the world faced a serious health challenge, the rapid spreading of a life-threatening viral pneumonia, coronavirus disease 2019 (COVID-19) caused by a betacoronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of January 2022 WHO statistics shows more than 5.6 million death and about 350 million infection by SARS-CoV-2. One of the life threatening aspects of COVID-19 is secondary infections and reduced efficacy of antibiotics against them. Since the beginning of COVID-19 many researches have been done on identification, treatment, and vaccine development. Bacterial viruses (bacteriophages) could offer novel approaches to detect, treat and control COVID-19. Phage therapy and in particular using phage cocktails can be used to control or eliminate the bacterial pathogen as an alternative or complementary therapeutic agent. At the same time, phage interaction with the host immune system can regulate the inflammatory response. In addition, phage display and engineered synthetic phages can be utilized to develop new vaccines and antibodies, stimulate the immune system, and elicit a rapid and well-appropriate defense response. The emergence of SARS-CoV-2 new variants like delta and omicron has proved the urgent need for precise, efficient and novel approaches for vaccine development and virus detection techniques in which bacteriophages may be one of the plausible solutions. Therefore, phages with similar morphology and/or genetic content to that of coronaviruses can be used for ecological and epidemiological modeling of SARS-CoV-2 behavior and future generations of coronavirus, and in general new viral pathogens. This article is a comprehensive review/perspective of potential applications of bacteriophages in the fight against the present pandemic and the post-COVID era. Highlights: Phages have a great promising potential for fighting against COVID-19. Phages could regulate host immune response by reducing inflammatory responses. Phage display could be used as a platform for new vaccines and antibodies discovery. Phages could be used as viral models for SARS-Cov-2. Phage therapy could be effective solution for respiratory bacterial infections.